Citadel Advisors’s Semler Scientific SMLR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-207,000
Closed -$3.17M 14134
2025
Q4
$3.17M Sell
207,000
-132,000
-39% -$2.99M ﹤0.01% 5069
2025
Q3
$10.2M Buy
339,000
+258,300
+320% +$8.89M ﹤0.01% 3244
2025
Q2
$3.13M Buy
80,700
+22,900
+40% +$816K ﹤0.01% 4911
2025
Q1
$2.09M Buy
57,800
+11,100
+24% +$520K ﹤0.01% 5454
2024
Q4
$2.52M Buy
+46,700
New +$2.15M ﹤0.01% 5160

Citadel Advisors's SMLR Position: Q1 2026 in Review

Citadel Advisors sold out of Semler Scientific (SMLR) in Q1 2026, closing a stake of 145,208 shares — an estimated $2.22M sold.

Citadel Advisors first reported a position in SMLR in Q4 2021 and held it in 13 quarters. The position peaked at $23.9M in Q2 2025. 0 funds tracked by Wall St. Rank hold SMLR as of Q1 2026.

  • Citadel Advisors reported no remaining Semler Scientific position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 145,208 Semler Scientific shares in Q1 2026, an estimated $2.22M.
  • Citadel Advisors first reported a position in Semler Scientific in Q4 2021 and held it in 13 quarters.
  • Citadel Advisors's Semler Scientific position peaked at $23.9M in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Semler Scientific as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.